| 产品名称 | Gavestinel - GV 150526A |
| 产品货号 | Axon 1262 CAS [153436-38-5] MF C18H11Cl2N2NaO3MW 397.19 Purity: 99% Soluble in DMSO Description In vivo potent and selective antagonist of glycine site of NMDA receptor; orally bioavailable; neuroprotective in animal models of ischaemic stroke References Certificates Categories Extra info Mugnaini et al. Receptor binding characteristics of the novel NMDA receptor glycine site antagonist [3H]GV150526A in rat cerebral cortical membranes. Eur. J. Pharmacol. 2002, 391, 233. Kajbaf et al. Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog. Xenobiotica. 2003, 33, 415. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS Pain & Inflammation NMDA Unclassified NMDA antagonist (glycine site) Chemical name 4,6-Dichloro-3-((E)-2-phenylcarbamoyl-vinyl)-1H-indole-2-carboxylic acid sodium salt Parent CAS No. [153436-22-7] Order Size Unit Price Stock 10 mg €110.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
Gavestinel - GV 150526AAxon 1262 CAS [153436-38-5] MF C18H11Cl2N2NaO3
Description
In vivo potent and selective antagonist of glycine site of NMDA receptor; orally bioavailable; neuroprotective in animal models of ischaemic stroke
NMDA antagonist (glycine site)
Chemical name4,6-Dichloro-3-((E)-2-phenylcarbamoyl-vinyl)-1H-indole-2-carboxylic acid sodium salt Parent CAS No.[153436-22-7] |
| 产品资料 |
